Literature DB >> 12665757

Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.

Sang-Heum Park1, James L Watkins, Evan L Fogel, Stuart Sherman, Laura Lazzell, Lois Bucksot, Glen A Lehman.   

Abstract

BACKGROUND: For patients with sphincter of Oddi dysfunction and abnormal pancreatic basal sphincter pressure, additional pancreatic sphincterotomy has been recommended. The outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction was evaluated.
METHODS: An ERCP database was searched for data entered from January 1995 to November 2000 on patients with sphincter of Oddi dysfunction who met the following parameters: sphincter of Oddi manometry of both ducts, abnormal pressure for at least 1 sphincter (> or =40 mm Hg), no evidence of chronic pancreatitis, and endoscopic dual pancreatobiliary sphincterotomy. Patients were offered reintervention by repeat ERCP if clinical symptoms were not improved. The frequency of reintervention was analyzed according to ducts with abnormal basal sphincter pressure, previous cholecystectomy, sphincter of Oddi dysfunction type, and endoscopic dual pancreatobiliary sphincterotomy method.
RESULTS: A total of 313 patients were followed for a mean of 43.1 months (median, 41.0 months; interquartile range: 29.8-60.0 months). Immediate postendoscopic dual pancreatobiliary sphincterotomy complications occurred in 15% of patients. Reintervention was required in 24.6% of patients at a median follow-up (interquartile range) of 8.0 (5.5-22.5) months. The frequency of reintervention was similar irrespective of ducts with abnormal basal sphincter pressure, previous cholecystectomy, or endoscopic dual pancreatobiliary sphincterotomy method. Of patients with type III sphincter of Oddi dysfunction, 28.3% underwent reintervention compared with 20.4% with combined types I and II sphincter of Oddi dysfunction (p = 0.105). When compared with endoscopic biliary sphincterotomy alone in historical control patients from our unit, endoscopic dual pancreatobiliary sphincterotomy had a lower reintervention rate in patients with pancreatic sphincter of Oddi dysfuntion alone and a comparable outcome in those with sphincter of Oddi dysfunction of both ducts.
CONCLUSION: Endoscopic dual pancreatobiliary sphincterotomy is useful in patients with pancreatic sphincter of Oddi dysfunction. Prospective randomized trials of endoscopic biliary sphincterotomy alone versus endoscopic dual pancreatobiliary sphincterotomy based on sphincter of Oddi manometry findings are in progress.

Entities:  

Mesh:

Year:  2003        PMID: 12665757     DOI: 10.1067/mge.2003.138

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  15 in total

Review 1.  Endoscopic papillotomy, syn. sphincterotomy: results from the past two years.

Authors:  Meinhard Classen; Peter Born
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 2.  Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically?

Authors:  Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2013-07-17       Impact factor: 3.452

Review 3.  Functional Pancreatic Sphincter Dysfunction in Children: Recommendations for Diagnosis and Management.

Authors:  Tom K Lin; Douglas S Fishman; Matthew J Giefer; Quin Y Liu; David Troendle; Steven Werlin; Mark E Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-12       Impact factor: 2.839

4.  Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial.

Authors:  Peter B Cotton; Valerie Durkalski; Joseph Romagnuolo; Qi Pauls; Evan Fogel; Paul Tarnasky; Giuseppe Aliperti; Martin Freeman; Richard Kozarek; Priya Jamidar; Mel Wilcox; Jose Serrano; Olga Brawman-Mintzer; Grace Elta; Patrick Mauldin; Andre Thornhill; Robert Hawes; April Wood-Williams; Kyle Orrell; Douglas Drossman; Patricia Robuck
Journal:  JAMA       Date:  2014-05       Impact factor: 56.272

5.  Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.

Authors:  Valerie Durkalski; Walter Stewart; Paulette MacDougall; Patrick Mauldin; Joseph Romagnuolo; Olga Brawman-Minzter; Peter Cotton
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

6.  Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro.

Authors:  Réka Sári; Attila Pálvölgyi; Zoltán Rakonczay; Tamás Takács; János Lonovics; László Czakó; Zoltán Szilvássy; Péter Hegyi
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 7.  Endoscopic therapy in acute recurrent pancreatitis.

Authors:  John Baillie
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 8.  Pancreatic ductal system obstruction and acute recurrent pancreatitis.

Authors:  M Delhaye; C Matos; M Arvanitakis; J Deviere
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 9.  Sphincter of Oddi dysfunction and bile duct microlithiasis in acute idiopathic pancreatitis.

Authors:  Grace-H Elta
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Sphincter of Oddi and its dysfunction.

Authors:  Prasad Seetharam; Gabriel Rodrigues
Journal:  Saudi J Gastroenterol       Date:  2008-01       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.